Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing clinical trial of pemafibrate in patients with impaired renal function
jRCT2031200177Completed
- Sponsor
- Kowa Company, Ltd.
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of pemafibrate in dyslipidemia (3 arms), sponsored by Kowa Company, Ltd. Primary endpoint: Pharmacokinetic parameter (AUC). Started Sep 2020; status: completed.
02
Drugs
pemafibrate
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on jRCT2031200177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031200177.